GlassScriptPhysician profile
Justo Maqueira
NPI 1790774420
$3,045.91
in general payments reported to CMS, 2019-2025
20 companies · $1,420 in 2025
The $1,420 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $85.74 · 2021: $308 · 2022: $264 · 2023: $485 · 2024: $93.08 · 2025: $1,420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $836 · Food and Beverage: $599 · Travel and Lodging: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $835.95 |
| Food and Beverage | $598.75 |
| Travel and Lodging | $562.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,440.52 | 2019-2025 | |
| Astellas Pharma US INC | $517.59 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $259.68 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $143.84 | 2019-2023 | |
| Pfizer INC. | $135.06 | 2019-2023 | |
| Coloplast Corp | $111.34 | 2021-2025 | Altis |
| Coopersurgical, INC. | $83.90 | 2022-2023 | Summit Doppler |
| Mayne Pharma Commercial LLC | $59.08 | 2021-2023 | |
| Duchesnay USA Incorporated | $54.82 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $53.56 | 2023 | Exparel |
| Roche Diagnostics Corporation | $49.39 | 2019 | |
| Therapeuticsmd, INC. | $24.23 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $23.10 | 2021 | |
| Hologic Sales and Service, LLC | $16.53 | 2021 | |
| Medtronic, INC. | $16.34 | 2025 | Ligasure |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $15.65 | 2022 | |
| Boston Scientific Corporation | $15.60 | 2024 | Solyx Sis System |
| Merck Sharp & Dohme LLC | $14.27 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.41 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justo Maqueira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.